Tay Salimullah Email and Phone Number
Tay Salimullah work email
- Valid
- Valid
Tay Salimullah personal email
Global MedTech | Strategic Board Advisor | Venture With over 20 years of leadership Pharma, Biotech and MedTech sectors, I specialize in advancing innovative therapies and building scalable commercial strategies. As former executive committee member at Novartis Gene Therapies, executed a new commercial model for speciality medicines, securing approvals in 55+ countries, treating 4,000+ patients, and driving $5B+ in revenue. My expertise spans drug development, pricing science, market access, and operational excellence in high-value healthcare solutions.My career includes impactful leadership roles across therapeutic areas, scientific modalities, data, diagnostics, and private equity. Now in the start-up world, advising early-stage biotech, VCs, and private equity, I focus on driving value for MedTech and pharma services indexed on transformative therapies. Passionate about delivering cutting-edge therapeutics, and frequently cited by top media outlets like the NYT, Fierce Biotech, the Financial Times, and featured on leading industry panels.
-
Founder, Managing General PartnerRenovamen Advisors LlcChicago, Il, Us
-
Venture Partner4Bio Capital Nov 2024 - PresentLondon, England, Gb4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector which is comprised of cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. -
Visiting FellowAlliance For Regenerative Medicine Nov 2024 - PresentWashington, District Of Columbia, UsProviding strategic counsel on ethics in genomic medicines, including pricing, access, industrialization, ultra-rare diseases, and advanced MedTech innovation. ARM is the global advocacy leader for genetic medicines, with a mission to enable durable, potentially curative therapies for patients worldwide. Representing 400+ members across 25 countries, uniting biotech innovators, researchers, and patient groups to drive policy, data insights, and healthcare modernization. -
Board Member & Chief Strategy OfficerTrogenix Oct 2024 - PresentTrogenix leverages cutting-edge technologies in genomics, oncology, immunotherapy, and gene therapy to pioneer next-generation cancer treatments. Using proven AAV vectors, our proprietary Synthetic Super-Enhancers (SSEs) target tumour cells with unmatched precision, exposing cancer to the immune system and destroying tumour cells. For any escaping cells, our 'Trojan horse' technology reawakens immunity, offering potentially curative, one-time treatments. With preclinical glioblastoma data showing curative potential, Trogenix is set to transform cancer care and explore applications beyond oncology. -
Managing General PartnerRenovamen Advisory Llc Sep 2024 - Present“Renovamen” derived from Latin, meaning “renewal” or “restoration.” It signifies the process of revitalization. Renovamen provides consulting and board services to early-stage biotech companies, venture capital, and private equity firms. Focused on MedTech. Recent projects inc. corp. strategy, US & global forecasting, evaluation of early-stage indications and strategic pricing.
-
Chief Access Officer (Formerly Avexis)Novartis Gene Therapies May 2020 - Oct 2024Basel, Baselstadt, ChMember of the executive committee. Built industry leading capabilities transforming AveXis from $8.7B acquisition into a pioneering worldwide multibillion-dollar gene therapy/rare disease business (neuroscience, retina gene therapy and Immunology). -
Head Global Business Franchise, Group Global HealthNovartis Global Health Apr 2018 - May 2020Basel, Basel-Town, ChLead enterprise wide global-health-access programs. Incubated and executed the Novartis Africa Sickle Cell Flagship Program. -
Global Strategic Projects Leader, Worldwide Real World EvidenceNovartis 2017 - 2018Basel, Baselstadt, ChCharacterization of real-world patient population and market access impact, following landmark results of a Phase III study which showed that targeting inflammation with ACZ885 reduces patients' risk of cardiovascular disease.
-
Ex.Director Us & Global Pricing & Market Access Cell & Gene TherapiesNovartis Mar 2015 - Apr 2017Basel, Baselstadt, ChStrongly contributed incubating the CAR-T business for Novartis. Developed and guided the organization on global value story for CAR-T- the first FDA approved CAR-T cell therapy.
-
Global Head Hematology Rwe ProgramNovartis Oncology Jul 2015 - Mar 2017Basel, Switzerland, ChSpearheaded disruptive $40m real-world-data public-private-partnership to shape access for personalized cancer therapies (partners include, 8 biopharma companies, physicians, payers, regulators, and European Hematology Association). -
Region Europe Market Access & Pricing DirectorNovartis 2013 - 2015Basel, Baselstadt, ChResponsible for integrated commercial market access (in market and pipeline) execution $2 billion portfolio of small molecules and innovative biologics across 28 markets.
-
Market Access Consultant - SingaporeAscendancy Healthcare 2012 - 2013Developed pricing and market access strategy for a US based company commercializing assets in ex Chinese Asian markets including (Australia, Philippines, Indonesia, Singapore, Malaysia, Vietnam, Thailand, Taiwan & Korea).
-
Assistant Vice President - SingaporeClermont Group 2011 - 2012Singapore, Singapore, SgThe Clermont Group (previously Chandler Corp.) is a private $billion investment group based in Singapore. Since 1986, investing in globally in public and private equity across a range of industries, including energy, financial services, consumer, and healthcare. -
Healthcare Strategy Lead - Oncology FranchisePfizer 2009 - 2011New York, New York, Us -
Head Strategic Market Access PayorsPfizer 2008 - 2009New York, New York, Us
-
Payor Strategy Leader - Strategic Market AccessPfizer 2007 - 2008New York, New York, Us
-
Commercial Director - Oncology FranchisePfizer 2005 - Aug 2007New York, New York, Us
-
Hospital Sales ManagerPfizer 2002 - 2005New York, New York, Us
-
Strategic Planning Consultant - AfricaUsaid 2009 - 2009Washington, District Of Columbia, UsPfizer Global Health Fellowship (in partnership with Boston School of Public Health). Worked with USAID to scale up a HIV data informatics program across Malawi. -
Primary Care Sales ExecutivePfizer 2000 - 2001New York, New York, Us
Tay Salimullah Skills
Tay Salimullah Education Details
-
Boston University School Of Public HealthInternational Public Health -
Brunel University Of LondonBsc Business Management Studies
Frequently Asked Questions about Tay Salimullah
What company does Tay Salimullah work for?
Tay Salimullah works for Renovamen Advisors Llc
What is Tay Salimullah's role at the current company?
Tay Salimullah's current role is Founder, Managing General Partner.
What is Tay Salimullah's email address?
Tay Salimullah's email address is ta****@****l.co.uk
What schools did Tay Salimullah attend?
Tay Salimullah attended Boston University School Of Public Health, Brunel University Of London.
What are some of Tay Salimullah's interests?
Tay Salimullah has interest in Disaster And Humanitarian Relief.
What skills is Tay Salimullah known for?
Tay Salimullah has skills like Market Access, Pharmaceutical Industry, Oncology, Business Strategy, Leadership, Strategy, International Development, Cross Functional Team Leadership, Cell And Gene Therapies, Immuno Oncology, Big Data.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial